Efficacy and Safety of Ribociclib in Combination With NSAI Versus Physician's Choice of Chemotherapy Sequential Endocrine Therapy in HR+/HER2- Advanced Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Advanced Breast Cancer
Related studies linked through entity extraction aliases.
A Study to Evaluate the Efficacy and Safety in Subjects With Advanced Breast Cancer Treated With SYHX2011
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Multicenter Clinical Study of Apatinib Mesylate Combined With Doctor's Choice for Advanced Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Evaluating the Incidence of Pseudo-Acute Kidney Injuries in Patients With Metastatic Breast Cancer on CDK4/6 Inhibitors Trough Cystatin C Analysis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
HCQ+ADC vs ADC in the Treatment of Advanced Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Dalpiciclib in HR+/HER2- ABC
- Status
- RECRUITING
- Phase
- N/A
Dose-Expansion Modular Study To Explore the Safety, Tolerability, and Anti-tumor Activity of HER3- DXd Monotherapy and Combinations in Patients With Inoperable Advanced Breast Cancer (ABC) After Progression on T-DXd
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Study on Pharmacokinetics of FCN-437c Capsule and Its Effect on QT Interval in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Sequencing Antibody Drug Conjugates in ER+/HER2 LOW/ULTRA LOW MBC
- Status
- RECRUITING
- Phase
- PHASE2
The Efficacy and Safety of Pyrotinib, Trastuzumab Combined With Taxanes in the Treatment of Trastuzumab-treated HER2+ Advanced Breast Cancer (ABC).
- Status
- RECRUITING
- Phase
- PHASE4
FUnctional Selection of Advanced Breast Cancer Patients for Talazoparib Treatment Using the REpair Capacity (RECAP) Test
- Status
- RECRUITING
- Phase
- PHASE2
Combination Followed by Maintenance Chemotherapy Versus CDK4/6 Inhibitor Combined With Endocrine Therapy for HR Low/HER2-negative Advanced Breast Cancer: a Prospective, Randomized, Open-label Phase Ⅱ Clinical Trial
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE2
Trastuzumab Emtansine (T-DM1) in HER2-positive Breast Cancer Patients With Progressive Disease After TKIs or HP Therapy
- Status
- RECRUITING
- Phase
- PHASE2
Prolonged Overnight Fasting and/or Exercise on Fatigue and Other Patient Reported Outcomes in Women With Hormone Receptor Positive Advanced Breast Cancer
- Status
- RECRUITING
- Phase
- NA
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
TIL Therapy for Patients With Advanced Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Organoid-based Functional Precision Therapy for Advanced Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Comparing the Pharmacokinetic Profile of LY01612 and CAELYX® in Chinese Subjects With Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Phase I Study of BEBT-209 in Women With Advanced Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE1